Sunday, November 15, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· March 3, 2026

IAMGOLD and OneSpaWorld have been highlighted as Zacks Bull and Bear of the Day

View original at finance.yahoo.com
IAMGOLD and OneSpaWorld have been highlighted as Zacks Bull and Bear of the Day For Immediate Release Chicago, IL – March 3, 2026 – Zacks Equity Research shares IAMGOLD IAG as the Bull of the Day and OneSpaWorld OSW as the Bear of the Day…
Opening lines of the source · short snapshot: read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • OneSpaWorld's spa treatments on cruises are discretionary squared, among first expenses cut when consumer confidence wobbles

    80% confidence
  • MetaMask Card allows users to spend directly from wallets without preloading funds onto centralized exchanges with assets remaining in users' control until transaction moment

    80% confidence
  • Mastercard partnership with MetaMask reinforces strategy of embedding deeper into digital asset ecosystem without taking balance sheet crypto risk

    80% confidence
  • New York regulatory clarity reduces friction and broadens addressable user base for crypto-linked cards

    80% confidence
  • Gold mining stocks are some of the best performing ones out there

    80% confidence
  • IAMGOLD is transitioning from rebuild mode to cash flow mode

    80% confidence
  • Gold prices have been living in record territory

    80% confidence
  • If adoption scales meaningfully, crypto-linked debit could drive incremental payment volume through Mastercard's network

    80% confidence
  • OneSpaWorld concentration risk in cruise lines becomes glaring when macro uncertainty increases

    80% confidence
  • When gold prices rise, margins expand fast due to high fixed costs in mining

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Conflicts between sources are checked by an editor before we publish them here.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,959
facts traced to their source, and we flag the ones that don't hold up.
101 entities tracked4,959 facts checked against source5,585 source documents archived
Query this data → isubstrate.com

Working data, not the finished story. This is what our AI has read and extracted from source documents so far. How we source

IAMGOLD and OneSpaWorld have been highlighted as Zacks Bull and Bear of the Day: Source | Via News | finance.via.news